SlideShare una empresa de Scribd logo
1 de 17
• Key Learning points about Dengue
  • Basic facts about Dengue
  • Surveillance and control practices
  • Communication and behavior change
  • Case management practices
  • Policies, laws and Regulations
  • FAQs

• Log Frame/Suggestions

• Visit locations

                                         5
• Contact emails for follow up
Differentiation between DF &
    Regional Approach
                                             DHF


Inter-sectoral collaboration       Judicious Monitoring


 Health communication &
                                    Fluid management
 Community participation

Integrated vector control &
                                        Research
   Vaccine development
                                                              6
• Surveillance
  – Reporting system
  – Response teams


• Control
  – Standardized case management
  – Prevention
     • Health education, IVM, research
                                         7
   Mass media campaigns         Fear & uncertainty

   Dengue day celebration       Source reduction

   Community participation      Live with Dengue

   Pursuance of stake           Reinforcement of
    holders                       behavior change      8
•   Standardized Referral system

•   Patient Triage by nursing staff

•   Composite monitoring charts

•   Indoor Laboratory Support

•   CBC analysis protocols
                                      9
   Regional approach and sustained partnership

   National Health Policy formulation

   Target oriented Insecticide Spray

   Law and regulation formulation


                                                  10
Frequently Asked Questions
Q:What are the symptoms of the disease?

     High grade fever.

     severe body aches and pains.

     Rash.

Q: Is it a deadly disease?

     No, if managed in time, curable,



Q: Does dengue spread from person to person?

     Mode of spread through mosquito bite.
                                               11

                                                    13
Frequently Asked Questions
Q:Can some one suffer from dengue again?
   Yes

Q:What are the warning signs for hospitalization?
   Deterioration of condition after settling of fever

   Giddiness

   Abdominal pain

   Persistent vomiting

   No urinary output for more than 4 hours

                                                         12
Frequently Asked Questions
Q: How can I protect my self and
family from dengue?
     Use of mosquito repellants/ insecticidal
      sprays, reducing mosquito breeding
      places.

Q: Is there any vaccine available?
     Not yet.

Q: What measures are needed to
prevent dengue in community?
     Public awareness
     Use     of    larvaecidals   and   other   13

      insecticides.
Frequently Asked Questions
Q:What      is   the   role   of   cultural/herbal
medications      for   cure   of   dengue     e.g.
papaya?

     No scientific proven role



Q:What to avoid?

     Red / coffee colored fluids, Asprin and
      Pain killers except paracetamol.
                                                     14
15
Log Frame
Planning             Indicators         Verification           Assumptions &
Elements                                Source                 Risks
Goal:
To reduce
dengue-related
mortality &
morbidity
Objective:           •Case Fatality     •Notification &        •Political
To increase health   Rate (CFR) of      Surveillance           commitment
workers capacity     DF/DHF reduced     reports                •Funds
to diagnose and      to < 0.5% within   •Institutional level   •Case definition &
treat                2 years            clinical /death        CFR
                     •Average length    auditing               standardization
                     of stay (ALS) in   •Death records         •Proper reporting
                     hospital           •Health facilities’
                                        records
                                                                                    16
Suggestions
   Increase capacity of health care providers
    to diagnose, monitor, treat and/or refer
    cases

   Strengthening of primary health care
    system

   Standardized referral and notification
    system in public and private sectors

   Improve laboratory support

   Improve public awareness                     17

Más contenido relacionado

La actualidad más candente

Homeless Sexual Health and Blood Borne Virus Outreach service
Homeless Sexual Health and Blood Borne Virus Outreach serviceHomeless Sexual Health and Blood Borne Virus Outreach service
Homeless Sexual Health and Blood Borne Virus Outreach service
lnnmhomeless
 
DOM_Research_Day_Poster 10.26.15
DOM_Research_Day_Poster 10.26.15DOM_Research_Day_Poster 10.26.15
DOM_Research_Day_Poster 10.26.15
Hayley Robinett
 
Bridging Evidence Based Medicine and Patient Centered Care: The Case of Local...
Bridging Evidence Based Medicine and Patient Centered Care: The Case of Local...Bridging Evidence Based Medicine and Patient Centered Care: The Case of Local...
Bridging Evidence Based Medicine and Patient Centered Care: The Case of Local...
Zackary Berger
 
Tim Quick 1
Tim Quick 1Tim Quick 1
Tim Quick 1
nacsconf
 
HIV COUNSELLING TESTING CAMPAIGN 2017
HIV COUNSELLING TESTING CAMPAIGN 2017 HIV COUNSELLING TESTING CAMPAIGN 2017
HIV COUNSELLING TESTING CAMPAIGN 2017
Andrew Mulenga
 
Psp mpc topic-08
Psp mpc topic-08Psp mpc topic-08
Psp mpc topic-08
Aya Kurata
 

La actualidad más candente (18)

Homeless Sexual Health and Blood Borne Virus Outreach service
Homeless Sexual Health and Blood Borne Virus Outreach serviceHomeless Sexual Health and Blood Borne Virus Outreach service
Homeless Sexual Health and Blood Borne Virus Outreach service
 
Translating evidence into patient information
Translating evidence into patient informationTranslating evidence into patient information
Translating evidence into patient information
 
Annual Epidemiological Presentation, 2017 - Kathleen Brady, PDPH
Annual Epidemiological Presentation, 2017 - Kathleen Brady, PDPHAnnual Epidemiological Presentation, 2017 - Kathleen Brady, PDPH
Annual Epidemiological Presentation, 2017 - Kathleen Brady, PDPH
 
DOM_Research_Day_Poster 10.26.15
DOM_Research_Day_Poster 10.26.15DOM_Research_Day_Poster 10.26.15
DOM_Research_Day_Poster 10.26.15
 
Strategies and Tactics to Leverage Social and Digital Media in Clinical Rese...
Strategies and Tactics to Leverage Social and Digital Media in Clinical Rese...Strategies and Tactics to Leverage Social and Digital Media in Clinical Rese...
Strategies and Tactics to Leverage Social and Digital Media in Clinical Rese...
 
CPE- The challenges facing healthcare organisations
CPE- The challenges facing healthcare organisationsCPE- The challenges facing healthcare organisations
CPE- The challenges facing healthcare organisations
 
Lynn Laidlaw and Suzanne morris vasculitis uk crdn summit 2017
Lynn Laidlaw and Suzanne morris vasculitis uk crdn summit 2017Lynn Laidlaw and Suzanne morris vasculitis uk crdn summit 2017
Lynn Laidlaw and Suzanne morris vasculitis uk crdn summit 2017
 
Chapter 7
Chapter 7Chapter 7
Chapter 7
 
Weitzman Echo on COVID-19 Team Based Care
Weitzman Echo on COVID-19 Team Based Care Weitzman Echo on COVID-19 Team Based Care
Weitzman Echo on COVID-19 Team Based Care
 
Bridging Evidence Based Medicine and Patient Centered Care: The Case of Local...
Bridging Evidence Based Medicine and Patient Centered Care: The Case of Local...Bridging Evidence Based Medicine and Patient Centered Care: The Case of Local...
Bridging Evidence Based Medicine and Patient Centered Care: The Case of Local...
 
Diabetes care and patient understanding of type 2 diabetes in remote, rural A...
Diabetes care and patient understanding of type 2 diabetes in remote, rural A...Diabetes care and patient understanding of type 2 diabetes in remote, rural A...
Diabetes care and patient understanding of type 2 diabetes in remote, rural A...
 
5. hcv test counselling final
5. hcv test counselling final5. hcv test counselling final
5. hcv test counselling final
 
Tim Quick 1
Tim Quick 1Tim Quick 1
Tim Quick 1
 
Beyond Privacy: Social Media’s Ethical Responsibility to the Clinical Trial P...
Beyond Privacy: Social Media’s Ethical Responsibility to the Clinical Trial P...Beyond Privacy: Social Media’s Ethical Responsibility to the Clinical Trial P...
Beyond Privacy: Social Media’s Ethical Responsibility to the Clinical Trial P...
 
HIV COUNSELLING TESTING CAMPAIGN 2017
HIV COUNSELLING TESTING CAMPAIGN 2017 HIV COUNSELLING TESTING CAMPAIGN 2017
HIV COUNSELLING TESTING CAMPAIGN 2017
 
From disease-centered to patient-centered communication in breast cancer
From disease-centered to patient-centered communication in breast cancerFrom disease-centered to patient-centered communication in breast cancer
From disease-centered to patient-centered communication in breast cancer
 
The Value of Online Communities
The Value of Online CommunitiesThe Value of Online Communities
The Value of Online Communities
 
Psp mpc topic-08
Psp mpc topic-08Psp mpc topic-08
Psp mpc topic-08
 

Similar a Awareness for dengue

Patient education for hiv and aids
Patient education for hiv and aidsPatient education for hiv and aids
Patient education for hiv and aids
Reynel Dan
 
STIs.pptx medicine and nursing powerpoit
STIs.pptx medicine and nursing powerpoitSTIs.pptx medicine and nursing powerpoit
STIs.pptx medicine and nursing powerpoit
1901600146
 
NTEP_ TB Laboratory Services_ 3-tier system _ PSM Made Easy.PDF
NTEP_ TB Laboratory Services_ 3-tier system _ PSM Made Easy.PDFNTEP_ TB Laboratory Services_ 3-tier system _ PSM Made Easy.PDF
NTEP_ TB Laboratory Services_ 3-tier system _ PSM Made Easy.PDF
Soujannya Kundu Chowdhury
 
Eficacia manejo de tratamiento responsabilidad uso medicamentos - CICATSALUD
Eficacia manejo de tratamiento   responsabilidad uso medicamentos - CICATSALUDEficacia manejo de tratamiento   responsabilidad uso medicamentos - CICATSALUD
Eficacia manejo de tratamiento responsabilidad uso medicamentos - CICATSALUD
CICAT SALUD
 

Similar a Awareness for dengue (20)

DFCM Pearls: What is New
DFCM Pearls: What is NewDFCM Pearls: What is New
DFCM Pearls: What is New
 
Leprosy management challenges
Leprosy management challengesLeprosy management challenges
Leprosy management challenges
 
Pharmacovigilance orientation
Pharmacovigilance orientationPharmacovigilance orientation
Pharmacovigilance orientation
 
Key approaches to rational use of drugs_DRDENON.pdf
Key approaches to rational use of drugs_DRDENON.pdfKey approaches to rational use of drugs_DRDENON.pdf
Key approaches to rational use of drugs_DRDENON.pdf
 
PIDSR
PIDSRPIDSR
PIDSR
 
Patient education for hiv and aids
Patient education for hiv and aidsPatient education for hiv and aids
Patient education for hiv and aids
 
GR AFHS Possible UTI.8.26.20 wo CE for ho.pptx
GR AFHS Possible UTI.8.26.20 wo CE for ho.pptxGR AFHS Possible UTI.8.26.20 wo CE for ho.pptx
GR AFHS Possible UTI.8.26.20 wo CE for ho.pptx
 
Ségolème Aymé - Infraestructuras de I + D para impulsar investigación en Enfe...
Ségolème Aymé - Infraestructuras de I + D para impulsar investigación en Enfe...Ségolème Aymé - Infraestructuras de I + D para impulsar investigación en Enfe...
Ségolème Aymé - Infraestructuras de I + D para impulsar investigación en Enfe...
 
Updates on COVID-19 Research: SECURE-IBD & IBD Partners
Updates on COVID-19 Research: SECURE-IBD & IBD PartnersUpdates on COVID-19 Research: SECURE-IBD & IBD Partners
Updates on COVID-19 Research: SECURE-IBD & IBD Partners
 
Antimicrobial Stewardship
Antimicrobial StewardshipAntimicrobial Stewardship
Antimicrobial Stewardship
 
Prof. Len Bowers, Kings College. Restraint Reduction Conference Keynote 27th ...
Prof. Len Bowers, Kings College. Restraint Reduction Conference Keynote 27th ...Prof. Len Bowers, Kings College. Restraint Reduction Conference Keynote 27th ...
Prof. Len Bowers, Kings College. Restraint Reduction Conference Keynote 27th ...
 
STIs.pptx medicine and nursing powerpoit
STIs.pptx medicine and nursing powerpoitSTIs.pptx medicine and nursing powerpoit
STIs.pptx medicine and nursing powerpoit
 
NTEP_ TB Laboratory Services_ 3-tier system _ PSM Made Easy.PDF
NTEP_ TB Laboratory Services_ 3-tier system _ PSM Made Easy.PDFNTEP_ TB Laboratory Services_ 3-tier system _ PSM Made Easy.PDF
NTEP_ TB Laboratory Services_ 3-tier system _ PSM Made Easy.PDF
 
1 elective 2 chronic care introduction
1 elective 2 chronic care introduction1 elective 2 chronic care introduction
1 elective 2 chronic care introduction
 
Imci
ImciImci
Imci
 
Project RSP! Training on PrEP for HIV Prevention
Project RSP! Training on PrEP for HIV PreventionProject RSP! Training on PrEP for HIV Prevention
Project RSP! Training on PrEP for HIV Prevention
 
Case Control Studies.pptx
Case Control Studies.pptxCase Control Studies.pptx
Case Control Studies.pptx
 
Brief Interventions for alcohol problems. OECD meeting.
Brief Interventions for alcohol problems. OECD meeting.Brief Interventions for alcohol problems. OECD meeting.
Brief Interventions for alcohol problems. OECD meeting.
 
Painfully unaware: Improving older people’s understanding of shingles vaccina...
Painfully unaware: Improving older people’s understanding of shingles vaccina...Painfully unaware: Improving older people’s understanding of shingles vaccina...
Painfully unaware: Improving older people’s understanding of shingles vaccina...
 
Eficacia manejo de tratamiento responsabilidad uso medicamentos - CICATSALUD
Eficacia manejo de tratamiento   responsabilidad uso medicamentos - CICATSALUDEficacia manejo de tratamiento   responsabilidad uso medicamentos - CICATSALUD
Eficacia manejo de tratamiento responsabilidad uso medicamentos - CICATSALUD
 

Más de Dr Muhammad Mustansar

Más de Dr Muhammad Mustansar (20)

students session
students sessionstudents session
students session
 
Lipid profile
Lipid profile Lipid profile
Lipid profile
 
Introduction of biochemistry
Introduction of  biochemistryIntroduction of  biochemistry
Introduction of biochemistry
 
BIOCHEMISTRY OF LIPIDS
BIOCHEMISTRY OF LIPIDSBIOCHEMISTRY OF LIPIDS
BIOCHEMISTRY OF LIPIDS
 
ECOSANOIDS
ECOSANOIDSECOSANOIDS
ECOSANOIDS
 
ROS ANTIOXIDENTS
ROS  ANTIOXIDENTSROS  ANTIOXIDENTS
ROS ANTIOXIDENTS
 
LIPID CHEMISTRY
LIPID CHEMISTRYLIPID CHEMISTRY
LIPID CHEMISTRY
 
Carcinogen
CarcinogenCarcinogen
Carcinogen
 
Infectious diseases
Infectious diseasesInfectious diseases
Infectious diseases
 
Differences of plasma osmolarity
Differences of plasma osmolarityDifferences of plasma osmolarity
Differences of plasma osmolarity
 
Introdction of metabolism
Introdction of metabolismIntrodction of metabolism
Introdction of metabolism
 
TRINITY COLLEGE ROBOTIC COMPETITION
TRINITY COLLEGE ROBOTIC COMPETITIONTRINITY COLLEGE ROBOTIC COMPETITION
TRINITY COLLEGE ROBOTIC COMPETITION
 
TRINITY COLLEGE ROBOTIC COMPETITION
TRINITY COLLEGE ROBOTIC COMPETITIONTRINITY COLLEGE ROBOTIC COMPETITION
TRINITY COLLEGE ROBOTIC COMPETITION
 
GLUCOSE TOLERANCE TEST
GLUCOSE TOLERANCE TESTGLUCOSE TOLERANCE TEST
GLUCOSE TOLERANCE TEST
 
Conference proceedings
Conference proceedings Conference proceedings
Conference proceedings
 
social media useage
social media useagesocial media useage
social media useage
 
DR MUHAMMAD MUSTANSAR
DR MUHAMMAD MUSTANSARDR MUHAMMAD MUSTANSAR
DR MUHAMMAD MUSTANSAR
 
STAINING TECHINIQUES
STAINING TECHINIQUESSTAINING TECHINIQUES
STAINING TECHINIQUES
 
Histopathology
HistopathologyHistopathology
Histopathology
 
Lactation
LactationLactation
Lactation
 

Último

The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
heathfieldcps1
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
ZurliaSoop
 

Último (20)

Plant propagation: Sexual and Asexual propapagation.pptx
Plant propagation: Sexual and Asexual propapagation.pptxPlant propagation: Sexual and Asexual propapagation.pptx
Plant propagation: Sexual and Asexual propapagation.pptx
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptxExploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 

Awareness for dengue

  • 1.
  • 2.
  • 3.
  • 4.
  • 5. • Key Learning points about Dengue • Basic facts about Dengue • Surveillance and control practices • Communication and behavior change • Case management practices • Policies, laws and Regulations • FAQs • Log Frame/Suggestions • Visit locations 5 • Contact emails for follow up
  • 6. Differentiation between DF & Regional Approach DHF Inter-sectoral collaboration Judicious Monitoring Health communication & Fluid management Community participation Integrated vector control & Research Vaccine development 6
  • 7. • Surveillance – Reporting system – Response teams • Control – Standardized case management – Prevention • Health education, IVM, research 7
  • 8. Mass media campaigns  Fear & uncertainty  Dengue day celebration  Source reduction  Community participation  Live with Dengue  Pursuance of stake  Reinforcement of holders behavior change 8
  • 9. Standardized Referral system • Patient Triage by nursing staff • Composite monitoring charts • Indoor Laboratory Support • CBC analysis protocols 9
  • 10. Regional approach and sustained partnership  National Health Policy formulation  Target oriented Insecticide Spray  Law and regulation formulation 10
  • 11. Frequently Asked Questions Q:What are the symptoms of the disease?  High grade fever.  severe body aches and pains.  Rash. Q: Is it a deadly disease?  No, if managed in time, curable, Q: Does dengue spread from person to person?  Mode of spread through mosquito bite. 11 13
  • 12. Frequently Asked Questions Q:Can some one suffer from dengue again?  Yes Q:What are the warning signs for hospitalization?  Deterioration of condition after settling of fever  Giddiness  Abdominal pain  Persistent vomiting  No urinary output for more than 4 hours 12
  • 13. Frequently Asked Questions Q: How can I protect my self and family from dengue?  Use of mosquito repellants/ insecticidal sprays, reducing mosquito breeding places. Q: Is there any vaccine available?  Not yet. Q: What measures are needed to prevent dengue in community?  Public awareness  Use of larvaecidals and other 13 insecticides.
  • 14. Frequently Asked Questions Q:What is the role of cultural/herbal medications for cure of dengue e.g. papaya?  No scientific proven role Q:What to avoid?  Red / coffee colored fluids, Asprin and Pain killers except paracetamol. 14
  • 15. 15
  • 16. Log Frame Planning Indicators Verification Assumptions & Elements Source Risks Goal: To reduce dengue-related mortality & morbidity Objective: •Case Fatality •Notification & •Political To increase health Rate (CFR) of Surveillance commitment workers capacity DF/DHF reduced reports •Funds to diagnose and to < 0.5% within •Institutional level •Case definition & treat 2 years clinical /death CFR •Average length auditing standardization of stay (ALS) in •Death records •Proper reporting hospital •Health facilities’ records 16
  • 17. Suggestions  Increase capacity of health care providers to diagnose, monitor, treat and/or refer cases  Strengthening of primary health care system  Standardized referral and notification system in public and private sectors  Improve laboratory support  Improve public awareness 17